Effectiveness and cost-effectiveness of height-screening programmes during the primary school years: A systematic review

Archives of Disease in Childhood

Volumn 93, Issue 4, 2008, Pages 278-284

  Fayter, D ^a   Nixon, J ^a   Hartley, S ^b   Rithalia, A ^a   Butler, G ^c   Rudolf, M ^b   Glasziou, P ^d   Bland, M ^a   Stirk, L ^a   Westwood, M ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF READING   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIBLIOGRAPHIC DATABASE; BODY HEIGHT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; GROWTH HORMONE DEFICIENCY; HUMAN; INFORMATION PROCESSING; PRIMARY SCHOOL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCREENING TEST; SYSTEMATIC REVIEW; TURNER SYNDROME; CHILD; CHILD HEALTH CARE; COST BENEFIT ANALYSIS; ECONOMICS; EVIDENCE BASED MEDICINE; GROWTH DISORDER; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; MASS SCREENING; METHODOLOGY; PRESCHOOL CHILD; STATISTICAL MODEL;

BODY HEIGHT; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; GROWTH DISORDERS; HEALTH SERVICES RESEARCH; HUMANS; MASS SCREENING; MODELS, ECONOMETRIC; PROGRAM EVALUATION;

EID: 42249091070     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.109843     Document Type: Review

References (39)

1. Lee SG. Does child health surveillance contribute to the detection of growth problems? A study of children referred to the growth clinic in Leeds [Master of Medical Science dissertation]. Leeds: University of Leeds, 1996.
2. Aynsley-Green A, Macfarlane JA. Method for the earlier recognition of abnormal stature. Arch Dis Child 1983;58:535-7.
3. Herber SM, Milner RD. When are we diagnosing growth hormone deficiency? Arch Dis Child 1986;61:110-2.
4. Massa G, Verlinde F, De Schepper J, et al. Trends in age at diagnosis of Turner syndrome. Arch Dis Child 2005;90:267-8.
5. Cotterill AM. An international perspective on height surveillance. J Med Screen 1995;2:171-3.
6. Hall DM, Voss LD. Growth monitoring. Arch Dis Child 2000;82:10-5.
7. Job JC. Early diagnosis and early treatment of growth hormone deficiency. Horm Res 1989;31:149-52.
8. Hyer W, Cotterill AM, Savage MO. Common causes of short stature detectable by a height surveillance programme. J Med Screen 1995;2:150-3.
9. Sarr M, Job JC, Chaussain JL, Golse B. Les retards de croissance psycogenes. Etude critique des elements de diagnostic. [Psychogenic growth retardation. Critical study of diagnostic data]. Arch Fr Pediatr 1987;44:331-8.
10. Centre for Community Child Health Royal Children's Hospital. Child health screening and surveillance a critical review of the evidence. Melbourne: National Health and Medical Research Council, 2002
11. National Screening Committee. Child health sub group report growth disorders. Leeds: National Screening Committee. 2004.
12. Hulse JA, Schilg S. United Kingdom community growth screening 1994 a survey of current practice. J Med Screen 1995;2:154-6.
13. van Buuren S, van Dommelen P, Zandwijken GR, et al. Towards evidence based referral criteria for growth monitoring Arch Dis Child 2004;89:336-41.
14. de Onis M, Wijnhoven TMA, Onyango AW. Worldwide practices in child growth monitoring. J Pediatr 2004;144:461-5.
15. NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. 2nd edn. York: NHS Centre for Reviews and Dissemination, 2001.
16. National Institute for Clinical Excellence. Guide to the methods of technology appraisal. London: National Insitute for Clinical Excellence; 2004 http://www.nice.org.uk/pdf/TAP_Methods.pdf.
17. Bryant J, Cave C, Mihaylova B, et al. Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation. Health Technol Assess 2002;6(18):1-168.
18. Banerjee S, Morgan RJ, Rees SA, et al. Height screening at school: ineffective without high standards and adequate resources. Arch Dis Child 2003;88:477-81.
19. Macfarlane A. Should we screen for growth problems in children? The pragmatic answer for 1994-5. J Med Screen 1994;1:50-9.
20. Department of Health. NHS reference costs 2004: NHS trust reference cost index. 2004. http://www.dh.gov.uk/PublicationsAndStatistics/ Publications/ PublicationsPolicyAndGuidance/ PublicationsPolicyAndGuidanceArticle/fs/ en?C0NTENT_ID=4105545&chk=znAfqu (accessed 29 Jan 2008).
21. Tapsfield R, Collier F. The cost of foster care: investing in our children's future. London: British Association for Adoption and Fostering and The Fostering Network; 2005, http://www.pssru.ac.uk.
22. Personal Social Services Research Unit. PSSRU website. PSSRU; 2006.
23. Birch S, Gafni A. The 'NICE' approach to technology assessment: an economics perspective. Health Care Management Science 2004;7:35-41.
24. Fayter D, Nixon J, Hartley S, et al. A systematic review of the routine monitoring of growth in children of primary school age to identify growth related conditions. Health Technol Assess 2007;11:1-182.
25. Anthony D, Stevens A Growth hormone in children development and valuation committee Report No 57 Bristol NHS Executive South West. 1996.
26. Busschbach JJ, Rikken B. Grobbee DE. et al Quality of life in short adults Horm Res 1998;49:32-8.
27. Office for National Statistics. Birth statistics review of the Registrar General on births and patterns of family building in England and Wales, 2004 London Office for National Statistics, 2005.
28. Agwu JC, Leishenring A, Darnley I. Community growth monitoiing in practice Arch Dis Child 2004;89:394.
29. de la Puente ML, Ibanez L, Marcos MV, et al. Cnbado problacional de crecimiento en atencion primaria. Grupo de Trabajo de Atencion Primaria. [Primary care population screening for growth]. Aten Primaria 1999;23:346-51.
30. Ahmed ML, Allen AD, Dunger DB, et al. The Oxford growth study: a district growth surveillance programme 1988-1994. J Med Screen 1995;2:160-3.
31. Lindsay R, Feldkamp M, Harris D, et al Utah Growth Study growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994;125:29-35.
32. Voss LD, Mulligan J, Betts PR, et al. Poor growth in school entrants as an index of organic disease: the Wessex Growth Study. BMJ 1992;305:1400-2.
33. Vimpani GV, Vimpanr AF, Pocock SJ, et al. Differences in physical characteristics, perinatal histories, and social backgrounds between children with growth hormone deficiency and constitutional short stature. Arch Dis Child 1981;56: 922-8.
34. Aszkenasy M. Audit of school entry growth screening. Middlesbrough, UK: Tees and North East Yorkshire NHS Trust, West Lane Hospital.
35. Lacey KA, Parkin JM. Causes of short stature. Lancet 1974;1:42-5.
36. Cernerud L, Edding E. The value of measuring height and weight of schoolchildren. Paediatr Perinat Epidemiol 1994;8:365-72.
37. Hearn S, Cotterill AM, Majrowski W, et al. Construction of a community height surveillance programme: the Hackney growth initiative. J Med Screen 1995;2:31-4.
38. Keller E, Gausche R, Meigen C, et al. Auxological computer based network for early detection of disorders of growth and weight attainment. J Pediatr Endocrinol 2002;15:149-56.
39. National Institute for Clinical Excellence. Guidance on the use of human growth hormone (somatropin) in children with growth failure. London: National Institute for Clinical Excellence (NICE): 2002 Report No.: Technology Appraisal no. 42. Available from: http://www.nice.org.uk/pdf/ HGHinChild-42-ALS.pdf.